Fluidigm, Sequenom, Foundation Medicine Shares Drop Sharply in May; Omics Tools/MDx Stocks Rise 3 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Fluidigm, Sequenom, and Foundation Medicine each saw big drops in their share prices month over month in May, while, overall, stocks in the omics tools and molecular diagnostics spaces improved about 3 percent. 

For May, 21 of the 31 firms in the GenomeWeb Index saw gains in their share prices, paced by Exact Sciences, whose stock rose 29 percent month over month. Meanwhile, NanoString Technologies' stock increased almost 18 percent, while Illumina's stock was up about 12 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.